Citadel Advisors »

Axsome Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $103M 1.3M 79.59
2023-09-30 $103M 1.5M 69.89
2023-06-30 $61M 846k 71.86
2023-03-31 $35M 566k 61.68
2022-12-31 $119M 1.5M 77.13
2022-06-30 $57M 1.5M 38.30
2022-03-31 $48M 1.2M 41.39
2021-12-31 $58M 1.5M 37.78
2021-09-30 $40M 1.2M 32.96
2021-06-30 $63M 937k 67.46
2021-03-31 $40M 704k 56.62
2020-12-31 $82M 1.0M 81.47
2020-09-30 $40M 558k 71.25
2020-06-30 $61M 739k 82.28
2020-03-31 $76M 1.3M 58.83
2019-12-31 $108M 1.0M 103.36
2019-09-30 $6.9M 342k 20.24
2019-06-30 $4.1M 161k 25.76
2019-03-31 $1.9M 134k 14.24
2018-06-30 $50k 16k 3.21
2016-09-30 $104k 13k 7.90